People In The News | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies said this week that it has appointed Ron Nersesian to be company president as well as chief operating officer, effective immediately.

Nersesian has been executive vice president and COO of Agilent since November 2011. In his new post, he will continue to be responsible for Agilent's Chemical Analysis, Life Sciences, Electronic Measurement, and Order Fulfillment businesses.


Definiens has named Gerald Möller to be chairman of the company's supervisory board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.